hydroxide ion has been researched along with Arthritis, Rheumatoid in 1 studies
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
Excerpt | Relevance | Reference |
---|---|---|
"To reduce the side effects of methotrexate and increase its anti-inflammatory effect, we developed a drug delivery system, dextran sulfate-modified methotrexate-loaded layered double hydroxide nanocomposites (LDH-MTX-DS), with both targeting and pH-sensitivity for the treatment of rheumatoid arthritis." | 4.02 | Dextran sulfate-modified pH-sensitive layered double hydroxide nanocomposites for treatment of rheumatoid arthritis. ( Su, M; Wang, X; Xi, M; Xu, X; Yang, B; Yin, Z, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Wang, X | 1 |
Yang, B | 1 |
Xu, X | 1 |
Su, M | 1 |
Xi, M | 1 |
Yin, Z | 1 |
1 other study available for hydroxide ion and Arthritis, Rheumatoid
Article | Year |
---|---|
Dextran sulfate-modified pH-sensitive layered double hydroxide nanocomposites for treatment of rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Dextran Sulfate; Hydrogen-Ion Concentration; Hydroxides; Methotrexat | 2021 |